Skip to content
VC FundPuts its own capital into companiesActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 13 SOURCES

Karista

Also known as Karista SAS, Karista VC, CapDecisif Management, CapDécisif

Paris early-stage VC created in 2001; seed to Series B in health, deep tech (space, defence, security) and digital; deploying Karista V (HealthTech) and Karista Tech I (SpaceTech, CNES-sponsored).

HEADQUARTERS
Paris, France
FOUNDED
2001
AUM
—
OUTSIDE CAPITAL
Yes
TEAM LISTED
8 people

Focus

STAGES
Pre-SeedSeedSeries ASeries B
SECTORS
HealthTechBiotech & Life SciencesSpaceDeep TechSoftware & SaaSMobility & Logistics
ASSET MIX
Venture capital
GEOGRAPHY
EuropeFranceGermanyBelgium

Overview

Karista is a Paris venture capital management company created in 2001 that invests from seed to Series B across health, deep tech and digital, usually as lead or co-lead with a board seat. In health and deep tech it makes initial investments of €1M–€6M and follows on up to €10M across Europe with a focus on France, DACH and Benelux; its Digital strategy invests €300k–€1M at pre-seed to pre-Series A in France. It is currently deploying Karista V, a HealthTech fund, and Karista Tech I, a SpaceTech fund sponsored by CNES. In 2026 it said it was preparing new strategies around HealthTech, space, defence and cybersecurity.

Investment thesis

Health: MedTech, BioTech and digital health (patient monitoring, DTx, clinical decision support, companion diagnostics, robotics, GenAI); €1M–€6M initial, up to €10M; Europe with focus on France, DACH, Benelux. DeepTech: space value chain, dual-use defence and security, cyber; €1M–€6M initial, up to €10M; Europe incl. Eastern Europe. Digital: smart city, proptech, mobility, fintech/insurtech, future of work; €300k–€1M initial, up to €3.5M; France.

PORTFOLIO (12)

  • ExotrailNOTABLE
    Space
  • NanobiotixNOTABLE
    Biotech & Life Sciences
  • Waiv
    HealthTech · since 2026
  • SamanTree Medical
    HealthTech · since 2025
  • TiHive
    Deep Tech · since 2025
  • Deemea
    HealthTech · since 2024
  • 10Lines
    Industrial & Manufacturing · since 2024
  • Constellr
    Space · since 2023
  • Look Up Space
    Space · since 2023
  • Rebrain
    HealthTech · since 2023
  • Beev
    Mobility & Logistics · since 2023
  • Fraiche Cancan
    Food & Agriculture · since 2021 · Acquired

People

  • Olivier Dubuisson
    Managing Partner; legal representative · source
  • Catherine Boule
    Managing Partner · source
  • Yvan-Michel Ehkirch
    Managing Partner · source
  • Baudouin Hue
    Partner · source
  • Benjamin Zerbib
    Partner · source
  • Emmanuel Daugeras
    Partner · source
  • Amine Benmoussa
    Partner · source
  • Agathe Biard
    Chief Compliance Officer · source

Links

Frequently asked questions

Karista is a VC fund based in Paris, France, founded in 2001.

Yes. Karista invests its own capital in private companies.

Karista invests at Pre-Seed, Seed, Series A and Series B stages in HealthTech, Biotech & Life Sciences, Space, Deep Tech, Software & SaaS and Mobility & Logistics.

Karista's stated ticket size is €300K–€6M.

Key people at Karista include Olivier Dubuisson (Managing Partner; legal representative), Catherine Boule (Managing Partner), Yvan-Michel Ehkirch (Managing Partner) and Baudouin Hue (Partner).

Karista's investments include Exotrail, Nanobiotix, Waiv, SamanTree Medical, TiHive, Deemea, 10Lines and Constellr, among others.

The most recent publicly reported investment by Karista is Waiv ($33M financing co-led by OTB Ventures and Alpha Intelligence Capital; Karista participating), announced in Mar 2026.

Karista states that it accepts submissions through its official contact page.

Yes. Karista manages capital from outside investors.